SG11201603346VA - Lactobacillus crispatus and application thereof - Google Patents

Lactobacillus crispatus and application thereof

Info

Publication number
SG11201603346VA
SG11201603346VA SG11201603346VA SG11201603346VA SG11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA SG 11201603346V A SG11201603346V A SG 11201603346VA
Authority
SG
Singapore
Prior art keywords
application
lactobacillus crispatus
crispatus
lactobacillus
Prior art date
Application number
SG11201603346VA
Inventor
Yang Liu
Original Assignee
Suzhou Osel Bio Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201310551630.3A external-priority patent/CN104630083B/en
Priority claimed from CN201310731833.0A external-priority patent/CN104178437B/en
Application filed by Suzhou Osel Bio Pharm Co Ltd filed Critical Suzhou Osel Bio Pharm Co Ltd
Publication of SG11201603346VA publication Critical patent/SG11201603346VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201603346VA 2013-11-08 2014-10-30 Lactobacillus crispatus and application thereof SG11201603346VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201310551630.3A CN104630083B (en) 2013-11-08 2013-11-08 A kind of Lactobacillus crispatus and its application in feminine care products
CN201310551661 2013-11-08
CN201310731833.0A CN104178437B (en) 2013-11-08 2013-12-26 A kind of Lactobacillus crispatus and the application in gynaecopathia thereof
PCT/CN2014/089882 WO2015067141A1 (en) 2013-11-08 2014-10-30 Lactobacillus crispatus and application thereof

Publications (1)

Publication Number Publication Date
SG11201603346VA true SG11201603346VA (en) 2016-05-30

Family

ID=53040891

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201603346VA SG11201603346VA (en) 2013-11-08 2014-10-30 Lactobacillus crispatus and application thereof

Country Status (9)

Country Link
US (1) US9937214B2 (en)
EP (1) EP3040413B1 (en)
JP (1) JP6890419B2 (en)
KR (1) KR101808972B1 (en)
ES (1) ES2670536T3 (en)
MY (1) MY172685A (en)
SG (1) SG11201603346VA (en)
TW (1) TWI652343B (en)
WO (1) WO2015067141A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109874329A (en) * 2016-08-12 2019-06-11 深圳华大生命科学研究院 A kind of production butyric acid is dwelt bacillus faecalis and its cultural method and application

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
EP3648778A4 (en) * 2017-07-07 2021-05-05 Osel, Inc. High potency stable formulations of vaginal lactobacillus
US11278581B2 (en) * 2017-07-07 2022-03-22 Osel, Inc. Use of vaginal Lactobacilli for improving the success rate of in vitro fertilization
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
AU2018346361B2 (en) 2017-10-06 2024-07-25 Gedea Biotech Ab Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
CN112384611B (en) * 2018-05-23 2024-01-09 Ko生物技术有限公司 Lactobacillus crispatus KBL693 strain and application thereof
GB201816425D0 (en) * 2018-10-09 2018-11-28 Tervisetehnoloogiate Arenduskeskus As Probiotics
CN109394796A (en) * 2018-12-06 2019-03-01 青岛东海药业有限公司 Lactobacillus crispatus preparation and its application
CN112458007A (en) * 2020-11-10 2021-03-09 深圳华大生命科学研究院 Lactobacillus crispatus for preventing and/or treating diseases related to genital tract flora disorder
FR3117340B1 (en) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Cosmetic, nutraceutical or dermatological use of a strain of Lactobacillus crispatus and/or of a composition comprising it
AU2021417032A1 (en) * 2021-01-05 2023-07-27 L'ORéAL S.A. Strains, compositions and methods of use
CN112899182B (en) * 2021-01-08 2023-03-24 安徽省肿瘤医院 Lactobacillus crispatus capable of preventing and/or treating cervical squamous cell carcinoma
CN113512509B (en) * 2021-05-07 2022-02-22 南方医科大学珠江医院 Lactobacillus crispatus and uses thereof
KR102618322B1 (en) * 2021-10-08 2023-12-27 순천향대학교 산학협력단 Novel Lactobacillus strain and composition for preventing, treating, or improving tuberculosis comprising the same
CN114214256B (en) * 2022-01-12 2022-06-28 哈尔滨美华生物技术股份有限公司 Lactobacillus gasseri for preventing and treating urogenital infection and application thereof
CN114657093B (en) * 2022-03-07 2023-07-07 北京市农林科学院 Pigeon-derived lactobacillus crispatus BL4014 and application thereof
CN115404185A (en) * 2022-08-31 2022-11-29 江苏新申奥生物科技有限公司 Lactobacillus crispatus LCP051 for antagonizing candida albicans and application thereof
CN116024129B (en) * 2022-11-29 2024-09-24 光明乳业股份有限公司 Lactobacillus crispatus capable of co-aggregating with helicobacter pylori and application thereof
CN116286484A (en) * 2023-02-08 2023-06-23 南昌大学 Lactobacillus crispatus and uses thereof
CN116769676B (en) * 2023-08-09 2023-12-05 杭州微致生物科技有限公司 Lactobacillus crispatus and application thereof
CN118256405B (en) * 2024-05-31 2024-08-13 哈尔滨医科大学 Lactobacillus crispatus FY121 and application of extracellular vesicles thereof in preventing and treating HPV infection and cervical cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US8329447B2 (en) 2008-12-12 2012-12-11 Osel, Inc. Strain of Lactobacillus crispatus
FR2992973B1 (en) * 2012-07-09 2015-12-18 S P M D NEW STRAIN OF LACTOBACILLUS CRISPATUS
CN103074270A (en) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 Lactobacillus crispatus and application
CN104178437B (en) * 2013-11-08 2016-08-24 苏州欧赛微科生物医药科技有限公司 A kind of Lactobacillus crispatus and the application in gynaecopathia thereof
CN104630083B (en) * 2013-11-08 2018-07-06 苏州欧赛微科生物医药科技有限公司 A kind of Lactobacillus crispatus and its application in feminine care products

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109874329A (en) * 2016-08-12 2019-06-11 深圳华大生命科学研究院 A kind of production butyric acid is dwelt bacillus faecalis and its cultural method and application

Also Published As

Publication number Publication date
WO2015067141A1 (en) 2015-05-14
TWI652343B (en) 2019-03-01
US20170020934A1 (en) 2017-01-26
EP3040413A1 (en) 2016-07-06
ES2670536T3 (en) 2018-05-30
EP3040413A4 (en) 2016-07-06
TW201531560A (en) 2015-08-16
JP2017501741A (en) 2017-01-19
EP3040413B1 (en) 2018-03-21
KR101808972B1 (en) 2017-12-13
JP6890419B2 (en) 2021-06-18
US9937214B2 (en) 2018-04-10
KR20160067893A (en) 2016-06-14
MY172685A (en) 2019-12-10

Similar Documents

Publication Publication Date Title
IL276106A (en) Anti-garp protein and uses thereof
IL261743B (en) Anti-il-33 antibodies and uses thereof
SG11201603346VA (en) Lactobacillus crispatus and application thereof
IL261547B (en) Anti-hepcidin antibodies and uses thereof
IL245040A0 (en) Anti-pdgfr-beta antibodies and uses thereof
IL243974A0 (en) Anti-prlr antibodies and uses thereof
ZA201508896B (en) Anti-c10orf54 antibodies and uses thereof
SG11201509116VA (en) Anti-tweakr antibodies and uses thereof
PL3058936T3 (en) Peptide composition and uses thereof
GB201309178D0 (en) Enzyme and uses thereof
GB201320992D0 (en) Complex and uses thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
EP3006564A4 (en) New peptide and application thereof
GB201301640D0 (en) Methods and peptides
GB201301022D0 (en) Composition and uses thereof